Publications by authors named "Helene T Stavnes"

Claim this Profile
M
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
Ben Davidson, Helene Tuft Stavnes, Ellen Hellesylt, Thomas Hager, Pio Zeppa

Hum Pathol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Helene Tuft Stavnes, Arild Holth, Trinh Don, Janne Kærn, Olga Vaksman

Gynecol Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
Helene Tuft Stavnes, Dag André Nymoen, Anita Langerød, Arild Holth, Anne-Lise Børresen Dale

Virchows Arch· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions.
Ben Davidson, Helene Tuft Stavnes, Björn Risberg, Jahn M Nesland, Jeremias Wohlschlaeger

Hum Pathol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
Mari Bunkholt Elstrand, Helene Tuft Stavnes, Claes G Tropé, Ben Davidson

Hum Pathol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.
Kjersti Brusegard, Helene Tuft Stavnes, Dag André Nymoen, Kjersti Flatmark, Claes G Trope

Virchows Arch· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA profiling along tumour progression in ovarian carcinoma.
Olga Vaksman, Helene Tuft Stavnes, Janne Kaern, Claes G Trope, Ben Davidson

J Cell Mol Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.
Ben Davidson, Helene Tuft Stavnes, Arild Holth, Xu Chen, Yanqin Yang

J Cell Mol Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival.
Ben Davidson, Helene Tuft Stavnes, Mette Førsund, Aasmund Berner, Anne Cathrine Staff

Breast· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.
Annika J Bock, Helene T Stavnes, Tibor Kempf, Claes G Tropè, Aasmund Berner

Int J Gynecol Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models.
Kjersti Flatmark, Ben Davidson, Alexandr Kristian, Helene Tuft Stavnes, Mette Førsund

Hum Pathol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Christina M Annunziata, Helene Tuft Stavnes, Lilach Kleinberg, Aasmund Berner, Lidia F Hernandez

Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
Sivan Elloul, Olga Vaksman, Helene Tuft Stavnes, Claes G Trope, Ben Davidson

Clin Exp Metastasis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
Yuan Yuan, Dag André Nymoen, Helene Tuft Stavnes, Anne Katrine Rosnes, Ola Bjørang

Am J Surg Pathol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Ben Davidson, Rivka Hadar, Helene Tuft Stavnes, Claes G Trope', Reuven Reich

Hum Pathol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis